发明名称 |
Selective inhibition of β1-adrenergic receptors for the treatment of pediatric heart failure |
摘要 |
Provided are methods of treating heart failure in children using B1-selective adrenergic receptor antagonists, alone or in combination with other agents, including B-2-selective adrenergic receptor agonists. |
申请公布号 |
US9456997(B2) |
申请公布日期 |
2016.10.04 |
申请号 |
US201113817969 |
申请日期 |
2011.08.25 |
申请人 |
THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE |
发明人 |
Stauffer Brian;Sucharov Carmen;Miyamoto Shelley |
分类号 |
A61K31/137;A61K31/138;A61K31/352;A61K45/06;A61K31/165;A61K31/35 |
主分类号 |
A61K31/137 |
代理机构 |
Parker Highlander PLLC |
代理人 |
Parker Highlander PLLC |
主权项 |
1. A method of treating dilated cardiomyopathy in a pediatric subject comprising administering to said subject an effective amount of a β1-adrenergic receptor-selective antagonist, wherein said β1-adrenergic receptor-selective antagonist is at least twice as β1-selective as Metoprolol. |
地址 |
Denver CO US |